Cidara Therapeutics, Inc., a biotechnology company developing long-acting therapeutics to transform the standard of care for patients facing serious fungal or viral infections, reported financial results for the three months ended March 31, 2020, and provided an update on its corporate activities and product pipeline.
May 13, 2020
· 7 min read